查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1930731

医疗设备射出成型市场：依材料、製程、应用和最终用途划分，全球预测（2026-2032年）

Medical Device Injection Molding Market by Material, Process Type, Application, End Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医疗设备射出成型市场规模将达到 90.4 亿美元，到 2026 年将成长至 96.8 亿美元，到 2032 年将达到 152.4 亿美元，复合年增长率为 7.74%。

关键市场统计数据
基准年 2025 90.4亿美元
预计年份：2026年 96.8亿美元
预测年份 2032 152.4亿美元
复合年增长率 (%) 7.74%

一个综合框架，涵盖了影响下一代医疗设备精密射出成型成型要求的各种新兴技术、监管和营运因素。

医疗设备射出成型领域的特点在于先进材料科学、严格的监管要求以及对运行稳定性的日益增长的需求三者交汇融合。近年来，製造商致力于开发更复杂的弹性体和工程塑胶组合，并将可製造性设计 (DFM) 与生物相容性要求和灭菌通讯协定相结合。随着医疗设备朝着小型化、整合流体通路和符合人体工学的照护现场应用设计方向发展，注塑成型合作伙伴被要求在确保材料认证和製程检验的前提下，提供更严格的公差、先进的表面光洁度和可重复的微观结构。

材料创新、工艺小型化、监管审查加强和供应链在地化等变革力量正在汇聚，重塑策略性射出成型伙伴关係。

随着技术、监管和商业性因素的融合，医疗器材产业正经历变革性的转折点，射出成型对医疗设备创新的支持方式也随之重塑。材料科学的进步，包括医用级液态硅胶配方和工程热塑性塑胶的出现，使得製造更复杂、整合度更高的零件成为可能，从而减少了组装步骤并提高了器械的可靠性。同时，微成型和包覆成型技术的成熟，使得设计人员能够将多组装结构整合到一个注塑成型的部件中，从而降低组装风险并改善产品的人体工学设计。

透过关税对医疗模具产业的采购、设计和采购流程进行累积调整，以优先保障供应链韧性和监管连续性。

到2025年，累积政策环境的累积变化对医疗设备射出成型供应链的影响远不止于直接的关税成本。贸易壁垒的增加和关税的重新分类正在改变筹资策略，促使原始设备製造商 (OEM) 和契约製造製造商重新评估供应商布局、前置作业时间和缓衝策略。实际上，这正推动各企业进一步实现关键供应链的本地化，实施跨区域的双重采购安排，并重新谈判长期供应商合同，以纳入关税减免条款和成本分摊机制。

基于深度细分的供应商选择洞察，将材料科学、专业成型製程、临床应用要求和机构最终用途要求连结起来。

细分市场分析揭示了材料、製程、应用和最终用途等方面的技术优先顺序和供应商能力存在差异。材料选择的压力涵盖了从液态硅橡胶的柔软性和生物相容性（适用于软密封件和患者接触界面）到热固性材料的刚度和尺寸稳定性（适用于结构部件）。热可塑性橡胶兼具弹性和可加工性，适用于一体式包覆成型零件，而工程热塑性塑胶则适用于高强度外壳和精密零件。每种材料系列都有其独特的模具设计考量、加工参数和下游检测要求，这些因素共同决定了供应商的资格标准。

影响美洲、欧洲、中东和非洲以及亚太地区采购和供应商发展的关键区域策略挑战和业务差异化因素

区域趋势为模具供应商和原始设备製造商 (OEM) 创造了不同的机会和营运需求。在美洲，接近性主要医疗设备製造商和快速反应的供应链备受重视，这推动了对认证製造流程、经过检验的品质系统、快速搬迁协助和本地灭菌检验能力的需求。与长程供应链相比，接近性优势有助于促进协作开发週期，加快模具迭代速度，缩短临床应用时间。

竞争优势源自于整合的技术能力、检验的品质体係以及将工程支援与供应链韧性结合的商业模式。

企业层面的策略正围绕着几个关键能力趋于一致：检验的材料组合、先进的微成型和包覆成型製程技术、健全的品管体系，以及将可製造性设计与持续供应相结合的服务模式。领先的供应商正在投资积层製造技术，以补充传统的模具製造工艺，从而实现快速原型製作，并缩短设计检验和生产之间的迭代周期。随着企业寻求控制关键的上游工程投入和灭菌流程，减少对外部的依赖，加快产品上市速度，策略伙伴关係和垂直整合正变得越来越普遍。

这是一本实用且跨职能的指导手册，整合了製造设计、数位化製程控制和弹性采购，以确保产品顺利上市。

产业领导者应优先考虑能够衔接设计意图、製程能力和采购弹性的协作策略，以保障临床试验进度和商业化进程。首先，应在研发生命週期的早期阶段就纳入材料和製程限制，透过正式设立製造设计关卡，要求供应商在最终确定模具之前提供意见。早期协调能够减少返工，缩短检验週期，并为监管机构提供清晰的指导。其次，应实现跨地区、跨能力采购的多元化，以减少单点故障，同时透过与指数挂钩的定价和产能承诺协议等合约条款，分担关税和供应波动带来的成本。

结合专家访谈、技术文献综述和交叉检验的多方面研究途径，确保了对射出成型的深入实践理解。

这些研究结果的基础是：对材料科学、法规事务、模具设计和采购领域的专家进行定性访谈，并辅以对已发布的法规指南和同行评审技术文献的审查。主要研究资料包括对模具工程师、品质经理和医疗设备OEM采购主管的结构化访谈，以了解其操作实务、模具策略和供应商选择标准。次要分析则评估了技术白皮书、生物相容性和灭菌方面的标准文件，以及已发表的关于微成型和包覆成型实施的案例研究。

策略和营运要务的综合分析表明，一体化能力、检验的流程和稳健的采购实践是医疗模具行业成功的关键。

医疗设备射出成型正从一项製造服务演变为一项影响产品设计、监管路径和供应链连续性的策略能力。随着材料和製程技术的日趋成熟，那些能够及早整合供应商专业知识、投资于製程检验和数位化监控，并制定兼顾成本和韧性的筹资策略的企业，将成为未来的赢家。日益严格的监管要求和贸易政策的逆风迫使采购、工程和品质部门紧密合作，并做出全面的决策，以管控风险并加快产品上市速度。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章医疗设备注塑射出成型市场（依材料划分）

  • 液态硅橡胶
  • 热塑性树脂
  • 热可塑性橡胶
  • 热固性树脂

第九章医疗设备注塑射出成型市场（依製程划分）

  • 嵌件成型
  • 微型成型
  • 包覆成型
  • 标准射出成型

第十章医疗设备注塑射出成型市场（依应用领域划分）

  • 循环系统器械
  • 诊断设备
  • 药物输送装置
    • 自动注射器
    • 笔式註射器
    • 预填充式注射器
  • 整形外科器械
  • 手术器械
    • 内视镜器械
    • 微创器械
    • 整形外科器械

第十一章医疗设备注塑射出成型市场（依最终用途划分）

  • 门诊手术中心
  • 诊所
  • 诊断检查室
  • 医院
  • 研究所

第十二章医疗设备注塑射出成型市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章医疗设备注塑射出成型市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国医疗设备射出射出成型市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国医疗设备射出射出成型市场

第十六章 中国医疗设备射出射出成型市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Accumold LLC
  • Amies Innovation Ltd.
  • Becton, Dickinson and Company
  • C&J Industries, Inc.
  • Currier Plastics, Inc.
  • EVCO Plastics, Inc.
  • Freudenberg Medical, LLC
  • Gerresheimer AG
  • Jabil Inc.
  • Nipro Corporation
  • Nolato AB
  • Phillips-Medisize Corporation
  • Proto Labs, Inc.
  • PTI Engineered Plastics, Inc.
  • SMC Ltd.
  • Spectrum Plastics Group, LLC
  • Stevanato Group SpA
  • Tessy Plastics Corp.
  • Viant Medical, Inc.
  • West Pharmaceutical Services, Inc.
Product Code: MRR-0A3806951A82

The Medical Device Injection Molding Market was valued at USD 9.04 billion in 2025 and is projected to grow to USD 9.68 billion in 2026, with a CAGR of 7.74%, reaching USD 15.24 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.04 billion
Estimated Year [2026] USD 9.68 billion
Forecast Year [2032] USD 15.24 billion
CAGR (%) 7.74%

A comprehensive framing of emerging technical, regulatory, and operational forces shaping precision injection molding requirements for next-generation medical devices

The medical device injection molding landscape is defined by the intersection of advanced materials science, rigorous regulatory expectations, and heightened operational resilience demands. Over recent years, manufacturers have navigated a more complex palette of elastomers and engineering plastics, integrating design for manufacturability with biocompatibility requirements and sterilization protocols. As devices evolve toward smaller form factors, integrated fluid pathways, and greater ergonomics for point-of-care use, molding partners are expected to deliver tighter tolerances, enhanced surface finishes, and reproducible microfeatures while maintaining certified materials and validated processes.

Operational leaders must reconcile volume, quality, and speed without compromising traceability or compliance. This requires close coordination among design engineers, process developers, and quality teams to ensure robust process controls, qualified materials, and validated assembly sequences. At the same time, a forward-looking commercial strategy must account for supplier concentration risks, the challenges of scaling micro and insert molding operations, and the strategic trade-offs between onshore manufacturing and regionalized supply chains. Transitioning from reactive problem solving to proactive capability development will be decisive for organizations seeking competitive differentiation in device reliability, time-to-market, and cost-to-manufacture.

Transformative confluence of material innovation, process miniaturization, regulatory scrutiny, and supply chain regionalization reshaping strategic injection molding partnerships

The industry is undergoing transformative shifts driven by converging technological, regulatory, and commercial forces that are redefining how injection molding supports medical device innovation. Advances in material science, including medical-grade liquid silicone formulations and engineered thermoplastics, are enabling more complex, integrated components that reduce assembly steps and improve device reliability. Concurrently, the maturation of micro molding and overmolding capabilities allows designers to collapse multi-component assemblies into single molded parts, driving down assembly risk and enhancing product ergonomics.

Regulatory frameworks are exerting greater influence on material selection and supplier qualification, prompting manufacturers to demand broader documentation, change-notice transparency, and enhanced batch-level traceability from molding partners. Economic and geopolitical pressures are accelerating strategic sourcing shifts; organizations are prioritizing supplier diversification and regional capacity investments to mitigate disruption. Digitalization in manufacturing-spanning process monitoring, SPC, and predictive maintenance-is improving yield and consistency while enabling more defensible regulatory submissions. Collectively, these shifts are raising the technical bar for molders and elevating the commercial expectations for service providers that can demonstrate validated processes, scalable microfabrication, and integrated quality systems.

Cumulative tariff-driven recalibration of sourcing, design, and procurement practices that prioritizes supply chain resilience and regulatory continuity in medical molding

The cumulative policy environment headed into 2025 has introduced layered implications for medical device injection molding supply chains that extend beyond immediate tariff costs. Higher trade barriers and tariff reclassifications have altered sourcing calculus, incentivizing OEMs and contract manufacturers to reassess supplier footprints, lead times, and buffer strategies. In practice, this has led organizations to explore greater localization of critical supply tiers, implement dual-sourcing arrangements across regions, and renegotiate supplier long-term agreements to include tariff mitigation clauses and cost-sharing mechanisms.

Beyond contract restructuring, the tariff landscape has amplified the importance of total landed cost analysis, encompassing not only duties but also inventory carrying costs, logistics variability, and regulatory compliance-related delays. Procurement teams are increasingly collaborating with design and process engineering to identify material substitutions and design simplifications that reduce tariff exposure while preserving clinical performance and regulatory compliance. Additionally, companies are investing in scenario planning and stress-testing supplier networks to quantify operational resilience against future policy shifts. The upshot is a strategic pivot from purely cost-driven sourcing to a resilience-oriented procurement model that balances regulatory certainty, supply continuity, and long-term competitiveness.

Deep segmentation-driven insights linking material science, specialized molding processes, clinical application demands, and institutional end-use requirements for supplier selection

Segmentation insights reveal differentiated technical priorities and supplier capabilities across material, process, application, and end-use axes. Based on material, selection pressures vary from the flexibility and biocompatibility of liquid silicone rubber for soft seals and patient-contact interfaces to the rigidity and dimensional stability of thermosets for structural components; thermoplastic elastomers offer a hybrid of elasticity and processability that suits integrated overmolded assemblies, while engineering thermoplastics support high-strength housings and precision features. Each material family imposes distinct tooling considerations, molding parameters, and downstream inspection requirements, which in turn shape supplier qualification criteria.

Based on process type, insert molding and overmolding demand tight positional tolerances and mature handling systems to ensure part-to-part repeatability, while micro molding necessitates specialized tool steel, flow analysis, and high-precision shot control to reproduce microfeatures reliably. Standard injection processes remain central for larger structural components where cycle time and cavity count drive economics. Based on application, the molding of cardiovascular device components requires metallurgical compatibility with implanted or blood-contact systems and often tighter sterilization validation paths; diagnostic devices emphasize optical clarity and dimensional consistency for sensor alignment; drug delivery devices prioritize surface finish and actuation reliability with sub-segmentation across auto-injectors, pen injectors, and prefilled syringes that each present unique tolerance and material migration considerations; surgical instruments include endoscopic, minimally invasive, and orthopedic instruments where sterilization cycles, mechanical endurance, and tactile feedback inform material and process selection. Based on end use, differences in operating environments and regulatory oversight influence supplier selection, with ambulatory surgical centers and clinics frequently requiring just-in-time delivery and smaller batch flexibility, diagnostic laboratories emphasizing consistency for high-throughput assays, hospitals requiring validated sterilization compatibility, and research institutes valuing rapid prototyping and iterative design support.

Across these segmentation dimensions, the critical insight is that alignment among material science, process capability, application-specific requirements, and end-use logistics determines supplier suitability more than price alone. Suppliers that demonstrate cross-functional expertise-combining validated materials portfolios, robust micro and insert molding capabilities, and service models aligned to clinical and institutional workflows-are positioned to capture higher-value partnerships.

Regional strategic imperatives and operational differentiators across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence sourcing and supplier development

Regional dynamics are creating differentiated opportunity windows and operational imperatives for molding suppliers and OEMs. In the Americas, emphasis is on proximity to large device manufacturers and rapid-response supply chains, driving demand for certified manufacturing practices, validated quality systems, and the ability to support accelerated transfers and localized sterilization validation. Proximity advantages also facilitate collaborative development cycles, enabling iterative tooling and faster time-to-clinical deployment when compared to long-haul supply chains.

In Europe, Middle East & Africa, regulatory harmonization and stringent material and biocompatibility standards push suppliers toward exhaustive documentation and traceability, while market fragmentation encourages regional partnerships and center-of-excellence models for specialized processes. This region frequently requires multilingual regulatory dossiers and flexibility to accommodate diverse reimbursement and procurement ecosystems. In Asia-Pacific, capacity expansion and competitive cost structures coexist with rapidly advancing technical capabilities, especially in micro molding and high-cavity tooling. However, buyers may require enhanced oversight on supplier quality systems and validation protocols to align with global regulatory expectations. Taken together, regional strategies must balance cost, regulatory alignment, and lead-time considerations, with hybrid sourcing models increasingly adopted to blend the operational strengths of different regions while mitigating concentration risks.

Competitive advantage driven by integrated technical capabilities, validated quality systems, and commercial models that align engineering support with supply resilience

Company-level strategies are converging around a few decisive capabilities: validated materials portfolios, advanced process expertise in micro and overmolding, robust quality management systems, and service models that integrate design for manufacturability with supply continuity. Leading suppliers are investing in additive capabilities to complement traditional tooling, enabling faster prototyping and reducing iteration cycles between design validation and production. Strategic partnerships and vertical integration are becoming more common where companies seek to control critical upstream inputs or sterilization steps, thereby reducing external dependencies and improving time-to-market.

Commercial differentiation increasingly comes from end-to-end offerings that blend engineering support, regulatory documentation, and configurable manufacturing capacity. Companies that can integrate SPC, real-time process monitoring, and batch-level traceability into their standard delivery packages create predictable outcomes for OEM customers and reduce the friction associated with regulatory submissions. At the same time, suppliers that emphasize flexible contractual models-such as capacity reservation, risk-sharing on tooling investments, and collaborative inventory management-are more attractive to innovative device firms that require agility. Finally, talent development and specialized training programs in mold design, microfabrication, and polymer science are emerging as competitive levers because they sustain capability depth and reduce reliance on external consultants during product transfers.

Actionable cross-functional playbook for leaders to integrate design for manufacturability, digital process controls, and resilient sourcing to secure product launches

Industry leaders should prioritize a coordinated strategy that bridges design intent, process capability, and procurement resilience to protect clinical timelines and commercial launches. First, embed material and process constraints earlier in the development lifecycle by formalizing design for manufacturability gates that require supplier input before tooling commitments. Early alignment reduces rework, shortens validation cycles, and creates clearer regulatory narratives for submissions. Next, diversify sourcing across regions and capabilities to reduce single-point failures, while negotiating contractual protections that share the cost of tariff and supply volatility through indexed pricing or capacity reservation agreements.

Invest in digital process controls and real-time monitoring to decrease variability and create defensible process capability evidence for regulatory inspections. Complement these investments with targeted supplier development programs that elevate smaller strategic partners into qualified, audited vendors capable of meeting clinical and sterilization requirements. Finally, adopt a scenario-based procurement playbook that maps supplier risk to contingency actions-ranging from dual-sourcing and safety-stock allocation to strategic onshoring of mission-critical components. By combining early-stage engineering collaboration with resilient sourcing and data-driven process control, leaders can reduce product launch risk and create a more agile manufacturing footprint that supports both innovation and compliance.

Multi-method research approach combining expert interviews, technical literature review, and cross-validation to ensure robust and practical injection molding insights

The research synthesis that informs these insights integrates qualitative interviews with subject matter experts across materials science, regulatory affairs, tooling engineering, and procurement, complemented by a review of public regulatory guidance and peer-reviewed technical literature. Primary inputs included structured interviews with molding engineers, quality leaders, and device OEM procurement executives to capture operational practices, tooling strategies, and supplier qualification criteria. Secondary analysis evaluated technical whitepapers, standards documents relating to biocompatibility and sterilization, and published case studies on micro molding and overmolding implementations.

Findings were triangulated through cross-validation sessions with independent engineering consultants and quality assurance specialists to ensure technical accuracy and practical applicability. The methodology prioritized thematic saturation and representative coverage across material types, process variations, and clinical applications, emphasizing reproducibility of technical claims and alignment with current regulatory expectations. Limitations include variability in proprietary supplier processes and the evolving nature of tariff policies, which may change the tactical implications for specific supply chains; nonetheless, the approach emphasizes durable strategic principles and operational best practices that are widely applicable.

Synthesis of strategic and operational imperatives showing how integrated capabilities, validated processes, and resilient sourcing determine success in medical molding

Medical device injection molding is transitioning from a transactional manufacturing service to a strategic capability that influences product design, regulatory pathways, and supply continuity. As materials and process technologies mature, the winners will be organizations that integrate supplier expertise early, invest in process validation and digital monitoring, and architect sourcing strategies that balance cost with resilience. Regulatory expectations and trade policy headwinds are forcing more holistic decision-making where procurement, engineering, and quality functions must collaborate closely to manage risk and accelerate time-to-market.

The practical takeaway is that technical excellence alone is no longer sufficient; suppliers and OEMs must pair capability with demonstrable quality systems, contractual agility, and data-driven process control to succeed. Organizations that implement cross-functional governance, prioritize validated materials and processes, and proactively manage supplier portfolios will be better positioned to meet clinical requirements and commercial timelines. In short, injection molding will continue to be a critical enabler of device innovation, but realizing that potential requires coordinated investments across engineering, quality, and supply chain disciplines.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Device Injection Molding Market, by Material

  • 8.1. Liquid Silicone Rubber
  • 8.2. Thermoplastic
  • 8.3. Thermoplastic Elastomer
  • 8.4. Thermoset

9. Medical Device Injection Molding Market, by Process Type

  • 9.1. Insert Molding
  • 9.2. Micro Molding
  • 9.3. Overmolding
  • 9.4. Standard Injection

10. Medical Device Injection Molding Market, by Application

  • 10.1. Cardiovascular Devices
  • 10.2. Diagnostic Devices
  • 10.3. Drug Delivery Devices
    • 10.3.1. Auto-Injectors
    • 10.3.2. Pen Injectors
    • 10.3.3. Prefilled Syringes
  • 10.4. Orthopedic Devices
  • 10.5. Surgical Instruments
    • 10.5.1. Endoscopic Instruments
    • 10.5.2. Minimally Invasive Instruments
    • 10.5.3. Orthopedic Instruments

11. Medical Device Injection Molding Market, by End Use

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Diagnostic Laboratories
  • 11.4. Hospitals
  • 11.5. Research Institutes

12. Medical Device Injection Molding Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Medical Device Injection Molding Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Medical Device Injection Molding Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Medical Device Injection Molding Market

16. China Medical Device Injection Molding Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Accumold LLC
  • 17.6. Amies Innovation Ltd.
  • 17.7. Becton, Dickinson and Company
  • 17.8. C&J Industries, Inc.
  • 17.9. Currier Plastics, Inc.
  • 17.10. EVCO Plastics, Inc.
  • 17.11. Freudenberg Medical, LLC
  • 17.12. Gerresheimer AG
  • 17.13. Jabil Inc.
  • 17.14. Nipro Corporation
  • 17.15. Nolato AB
  • 17.16. Phillips-Medisize Corporation
  • 17.17. Proto Labs, Inc.
  • 17.18. PTI Engineered Plastics, Inc.
  • 17.19. SMC Ltd.
  • 17.20. Spectrum Plastics Group, LLC
  • 17.21. Stevanato Group S.p.A.
  • 17.22. Tessy Plastics Corp.
  • 17.23. Viant Medical, Inc.
  • 17.24. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY LIQUID SILICONE RUBBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY LIQUID SILICONE RUBBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY LIQUID SILICONE RUBBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOPLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOPLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOPLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOSET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOSET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY THERMOSET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY INSERT MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY INSERT MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY INSERT MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MICRO MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MICRO MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MICRO MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY OVERMOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY OVERMOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY OVERMOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY STANDARD INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY STANDARD INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY STANDARD INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY AUTO-INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY AUTO-INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PEN INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PEN INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PREFILLED SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PREFILLED SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ORTHOPEDIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ORTHOPEDIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ORTHOPEDIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ENDOSCOPIC INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ENDOSCOPIC INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ENDOSCOPIC INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MINIMALLY INVASIVE INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ORTHOPEDIC INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ORTHOPEDIC INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY ORTHOPEDIC INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GCC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 147. GCC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. GCC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 150. GCC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 151. GCC MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. G7 MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. G7 MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. G7 MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. G7 MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 172. G7 MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 173. NATO MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. NATO MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. NATO MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. NATO MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. NATO MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. NATO MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 179. NATO MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA MEDICAL DEVICE INJECTION MOLDING MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)